Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 601, pseudogene (RNU6-601P) is a human genomic pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. Genuine U6 snRNA is a crucial non-coding RNA that forms part of the spliceosome complex responsible for pre-mRNA splicing in the nucleus. However, pseudogenes such as RNU6-601P are non-functional genomic DNA sequences that resemble functional snRNA genes but do not encode active products[2][3]. These U6 pseudogenes may arise through gene duplication or retrotransposition events and often contain sequence elements of U6 RNA (including both authentic 5′ and 3′ ends)[3]. In contrast to functional U6 snRNA, RNU6-601P and similar pseudogenes do not participate in splicing nor serve as receptors, enzymes, or other typical drug targets. There are no known drugs, disease links, or validated biomarker roles for this pseudogene. Its presence is principally of genomic interest, reflecting evolutionary events, rather than functional or therapeutic significance[3]. The "601" and "pseudogene" designation indicate this is one of many non-functional ("backup" or historical) copies of the U6 snRNA gene scattered in vertebrate genomes[2][3]. Functional U6 snRNA belongs to the snRNA family, is highly conserved, and is essential for spliceosome function in eukaryotes[1][2]. Pseudogenes such as RNU6-601P are not considered therapeutic targets, molecular receptors, or enzymes[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 601, pseudogene (RNU6-601P).